51猎奇入口

51猎奇入口鈥檚 Technology Licensing Office (TLO) plays a central role in translating research into real鈥憌orld impact, working with faculty, students and industry partners to move innovations beyond the lab.

Focused on intellectual property protection and commercialization, the TLO helps researchers navigate the path from discovery to application, ensuring technologies from 51猎奇入口labs can deliver social and economic benefits.

The Government of Canada's Research Support Fund (RSF) provides for a team of experts at the TLO that helps creators protect their intellectual property (IP) and navigate regulatory and commercialization barriers. These positions also help 51猎奇入口researchers build effective working relationships with communities, industry, governments, and non-profits to increase the capabilities of their technologies.

Through services such as patenting support, industry matchmaking and licensing negotiations, the TLO connects 51猎奇入口research with companies and investors, while guiding decisions about whether technologies are best advanced through licensing agreements or startup ventures.

It also supports early-stage commercialization strategies and funding opportunities, helping researchers bring their work to market and expanding SFU鈥檚 role as a driver of innovation in British Columbia and beyond.

鈥淧artnering with the TLO was instrumental to our early success in raising substantial grants that enabled us to build the technical team behind the novel technology and, over time, assemble a seasoned management team,鈥� says Andy Hoffer, the lead inventor and founder of , whose patented device helps free ICU patients from mechanical ventilators.

鈥淭he TLO also helped us develop our patent strategy, establish licensing agreements and adopt an appropriate business model, while attracting two waves of private investment and advancing the technology through lengthy pre-clinical validation phases,鈥� says Hoffer.

Lungpacer has since received clearance from the U.S. Food and Drug Administration (FDA) to commercialize its first product, which is now being used to stabilize patients鈥� breathing in a growing number of hospitals.

• Learn more about Andy Hoffer and Lungpacer鈥檚 journey from university invention to lifesaving innovation

The RSF contributes to SFU's ability to provide a supportive research environment and arm 51猎奇入口researchers with the tools, information and resources they need to commercialize university technologies.

鈥淭hanks to support from the RSF, the TLO is able to guide innovators at the outset to make the best legal and business decisions to validate and commercialize their technologies,鈥� says Kamaldeep Singh Sembi, director and IP legal counsel of the TLO.

鈥淥ur office also complements other interdisciplinary 51猎奇入口programs that provide entrepreneurial mindset training for scientists and engineers to commercialize their technologies, such as the . This helps keep university discoveries and IP in Canada, while also attracting expertise from around the world.鈥�

• Learn how SFU鈥檚 innovation ecosystem drives spinoff success

That breadth and depth of support and expertise helped 51猎奇入口earn recognition as Canada's top university for innovation in the for the sixth consecutive year.

Globally, 51猎奇入口placed 14th among 500 universities. 51猎奇入口also ranked first among Canadian institutions for university-based entrepreneurial projects.